People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Quantum Immunologics, Inc. | — | Pharmaceuticals | Seed | $8.0M | $62.1M | 2010 |
Raymond Wingard at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Raymond Wingard on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Donald Wright | 1 | 8 |
| David Harris | 1 | 6 |
| David J Bryant | 1 | 2 |
| Steve Allison | 1 | 1 |
| Taina Broes | 1 | 1 |
| Barry Rooth | 1 | 1 |
| Cortland Reilly | 1 | 1 |
| Josh Coughlin | 1 | 1 |
| Charles Broes | 1 | 1 |
| Martin P. Eason | 1 | 1 |
| Bernaldo P. Bicoy | 1 | 1 |
| Josh P. Coughlin | 1 | 1 |
| Taina P. Broes | 1 | 1 |
| Barry P. Rooth | 1 | 1 |
| Donald P. Wright | 1 | 1 |
| Martin Eason | 1 | 1 |
| Bernie Bicoy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.